Trial Profile
Phase II trial of oral HEP-114 in patients with toxic liver injury
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Apr 2015
Price :
$35
*
At a glance
- Drugs Hep 114 (Primary)
- Indications Liver injury
- Focus Pharmacodynamics
- Sponsors TGV-Laboratories
- 15 Apr 2015 New trial record